Keyphrases
AIDS/HIV
44%
Amygdala
25%
Anger
9%
Brain Volume
24%
Cardiovascular Disease
15%
CD4 Nadir
12%
Cerebral Hypoperfusion
10%
Cerebral Perfusion
22%
Cognitive Dysfunction
12%
Cognitive Function
10%
Cognitive Functioning
10%
Cognitive Impairment
16%
Combined Antiretroviral Therapy (cART)
12%
Confidence Interval
18%
Coping Mechanisms
15%
Cortical Thickness
17%
COVID-19
18%
COVID-19 Pandemic
32%
Early Life Stress
38%
Emotion Recognition
12%
Emotional Faces
15%
Executive Function
26%
Facial Emotion Recognition
26%
Functional Magnetic Resonance Imaging
14%
Generalized Anxiety Disorder
11%
Healthcare Workers
17%
Healthy Controls
16%
Highly Active Antiretroviral Therapy (HAART)
10%
HIV Patients
14%
HIV+
31%
HIV-associated Neurocognitive Disorders
15%
Human Immunodeficiency Virus Infection
16%
Intraindividual Variability
10%
Neurobehavior
17%
Neurocognitive Function
13%
Neuropsychiatric Symptoms
21%
Odds Ratio
19%
Older Adults
52%
Parkinson's Disease
17%
People Living with HIV (PLHIV)
14%
Posttraumatic Stress Disorder
10%
Reaction Time
10%
Reaction Time Variability
15%
Stress Exposure
11%
Substance Use
15%
Synergistic Effect
15%
Telephone
10%
Ventral Striatum
10%
Visual Scanning
9%
Young Adulthood
9%
Neuroscience
Adverse Effect
11%
Alcohol Abuse
7%
Amygdala
32%
Antihypertensive Agent
7%
Arterial Spin Labeling
15%
Basal Ganglia
5%
CD4
9%
Central Nervous System
8%
Cerebrovascular Disease
9%
Cognitive Disorders
28%
Cognitive Function
12%
Decision-Making
7%
Executive Function
6%
Frontal Lobe
12%
Functional Connectivity
9%
Functional Magnetic Resonance Imaging
13%
Generalized Anxiety Disorder
5%
Gray Matter
8%
Hepatitis C
7%
HIV Associated Dementia
13%
Human Immunodeficiency Virus
100%
Language Delay
7%
Longitudinal Study
9%
Magnetic Resonance Imaging
25%
Neuropathy
7%
Paclitaxel
7%
Parietal Lobe
7%
Parkinson's Disease
15%
Placebo
5%
Substance Abuse
15%
Temporal Lobe
10%
Variable Number Tandem Repeat
7%
Vascular Disease
6%
Ventral Striatum
10%
Working Memory
9%